Indeed, specific components of the ghrelin system, and especially GOAT, displayed remarkable alterations and clinical-histological correlations in tumor tissues, suggesting their potential value as novel biomarkers in GEP-NETs. The gene discussed is GHRL; the disease is neoplasm.